These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 20059561)

  • 1. Inhibitors of factor VIII in hemophilia.
    Santos A; Annichino-Bizzacchi JM; Ozelo MC
    N Engl J Med; 2009 Jul; 361(3):309-10; author reply 310. PubMed ID: 19610164
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19-month-old male with severe hemophilia A.
    Mistretta JN; Español MG; Tarantino MD; Christ DC; Jones MD; Roberts JC
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31081. PubMed ID: 38753403
    [No Abstract]   [Full Text] [Related]  

  • 3. New targeted therapy for hemophilia.
    Preston RJS
    Blood; 2023 Sep; 142(12):1032-1034. PubMed ID: 37733378
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of factor VIII in hemophilia.
    Eckhardt CL; Kamphuisen PW; Fijnvandraat K
    N Engl J Med; 2009 Jul; 361(3):309; author reply 310. PubMed ID: 19610163
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitors of factor VIII in hemophilia.
    Lacroix-Desmazes S; Dimitrov JD; Repesse Y
    N Engl J Med; 2009 Jul; 361(3):308; author reply 310. PubMed ID: 19605840
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
    Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of a premature infant with haemophilia A and factor VIII inhibitor.
    Cartledge P; Deakin K; McKecknie L; Richards M
    Haemophilia; 2011 Jul; 17(4):711-2. PubMed ID: 21371187
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia.
    O'Brien JR
    Proc R Soc Med; 1967 Mar; 60(3):243-4. PubMed ID: 6020147
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: 'Haemophilia: new challenges and winning directions'.
    Santagostino E; Franchini M
    Haemophilia; 2010 Jan; 16 Suppl 1():1. PubMed ID: 20059561
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.
    Gouw SC; van den Berg HM
    Semin Thromb Hemost; 2009 Nov; 35(8):723-34. PubMed ID: 20169509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.